Cost-effectiveness of a fixed-dose combination agent in high-risk hypertensive patients

被引：0
|
作者：
Faulkner, MA [1 ]
Hilleman, DE [1 ]
Reyes, AP [1 ]
机构：
[1] Creighton Univ, Div Cardiol, Omaha, NE 68178 USA
来源：
AMERICAN JOURNAL OF HYPERTENSION | 2004年 / 17卷 / 05期
关键词：
fixed-dose combination therapy; trandolapril/Verapamil; blood pressure goals;
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
P196
引用
收藏
页码：105A / 105A
页数：1
相关论文
共 50 条
  • [41] Cost-effectiveness of telemonitoring for high-risk pregnant women
    Buysse, Heidi
    De Moor, Georges
    Van Maele, Georges
    Baert, Erik
    Thienpont, Geert
    Temmerman, Marleen
    INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS, 2008, 77 (07) : 470 - 476
  • [42] Incremental benefit and cost-effectiveness of high-dose statin therapy in high-risk patients with coronary artery disease
    Chan, Paul S.
    Nallamothu, Brahmajee K.
    Gurm, Hitinder S.
    Hayward, Rodney A.
    Vijan, Sandeep
    CIRCULATION, 2007, 115 (18) : 2398 - 2409
  • [43] ANTIHYPERTENSIVE EFFICACY OF TRIPLE DRUGS FIXED COMBINATION THERAPY OF HIGH-RISK HYPERTENSIVE PATIENTS
    Nagay, A.
    Khamidullaeva, G.
    Abdullaeva, G.
    Khafisova, L.
    JOURNAL OF HYPERTENSION, 2017, 35 : E191 - E191
  • [44] Cost-Effectiveness of a Fixed-Dose Combination Pill for Secondary Prevention of Cardiovascular Disease in China, India, Mexico, Ghana, and South Africa
    Lin, John K.
    Moran, Andrew E.
    Tobias, Andrea P.
    Kazi, Dhruv S.
    CIRCULATION, 2016, 134
  • [45] What Makes Prescribers Switch to Fixed-Dose Combination Therapy for Japanese Hypertensive Patients?
    Kusama, Makiko
    Zeniya, Shigeki
    Fukuoka, Katsushi
    Akazawa, Manabu
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 140 - 140
  • [46] Cost-Effectiveness of a Fixed-Dose Combination Pill for Secondary Prevention of Cardiovascular Disease in China, India, Mexico, Ghana, and South Africa
    Lin, John K.
    Moran, Andrew E.
    Tobias, Andrea P.
    Kazi, Dhruv S.
    CIRCULATION, 2016, 134
  • [47] HPLC–DAD Analysis of Hydrochlorothiazide and Irbesartan in Hypertensive Patients on Fixed-Dose Combination Therapy
    François Coudoré
    Laurent Harvard
    Sandrine Lefeuvre
    Eliane M. Billaud
    Philippe Beaune
    Guillaume Bobrie
    Michel Azizi
    Patrice Prognon
    Stéphane Laurent
    Chromatographia, 2011, 74 : 559 - 565
  • [48] COST-EFFECTIVENESS OF ROSUVASTATIN/EZETIMIBE THERAPY IN HIGH-RISK HYPERTENSIVE PATIENTS WITH UNCONTROLLED HYPERCHOLESTEROLEMIA BY A PREVIOUS SIMVASTATIN/EZETIMIBE TREATMENT
    Mazza, A.
    Torin, G.
    D'Amicis, C.
    Schiavon, L.
    Sacco, A. P.
    Lenti, S.
    JOURNAL OF HYPERTENSION, 2019, 37 : E228 - E228
  • [49] Fixed-dose combination antihypertensives and risk of medication errors
    Moriarty, Frank
    Bennett, Kathleen
    Fahey, Tom
    HEART, 2019, 105 (03) : 204 - 209
  • [50] COST-EFFECTIVENESS OF A FIXED DOSE COMBINATION OF ALENDRONATE AND CHOLECALCIFEROL IN THE TREATMENT OF WOMEN WITH OSTEOPOROSIS AT RISK FOR VITAMIN D DEFICIENCY
    Ghosh, Sabyasachi
    Fan, Tao
    Modi, Ankita
    Jansen, Jeroen
    Sen, Shuvayu
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 : 132 - 133
12345